Colorectal Surgery Device Prevents Need for Ostomy
|
By HospiMedica International staff writers Posted on 05 Feb 2018 |

Image: The Colovac endoluminal bypass sheath protects against anastomotic leakage (Photo courtesy of SafeHeal).
A new endoluminal bypass sheath could help surgeons avoid the need for a diverting ostomy in patients undergoing colectomy.
The SafeHeal (Paris, France) Colovac device is a seamless, minimally invasive, and fully reversible flexible bypass sheath that is intended to reduce any contact of fecal content with the colorectal anastomotic site, following open or laparoscopic colorectal surgery. It is anchored above the anastomosis using a stent combined with a vacuum-based mechanism; once in place, the implant covers the colon down to the anus, remaining in place until healing and tissue repair processes are complete, after which it is removed in an endoscopic procedure.
Colovac thus enables patients to resume their normal life without having to bear an artificial anus and wear ostomy pouches for several months. For the device’s European CE mark study, 15 colorectal surgery patients initially scheduled to receive a diverting ostomy will receive a Colovac device in lieu of the ostomy. The two first procedures were recently carried out at the Institute of Image-Guided Surgery (Strasbourg, France), in collaboration with CHU de Strasbourg (France).
“There is a high clinical and economic need for a disruptive product such as Colovac, which effectively reduces anastomotic leakage rates following colorectal surgery, while avoiding the distressing impacts of an ostomy for patients,” said Karl Blohm, CEO of SafeHeal. “This trial is a significant milestone in moving SafeHeal towards regulatory approval in Europe and the US.”
“In the two cases we performed, the Colovac procedure was very simple, safe and well received by the patients. We look forward to further participating in the clinical evaluation of this technology,” said digestive surgeon Antonio D’Urso, MD, principal investigator of the study. “Based on this early experience, the trial confirms the good usability of the device, its placement and retrieval, in line with preclinical experiments.”
Anastomotic leakage occurs in up to 20% of patients undergoing anterior resection. It is considered to be the most serious colorectal surgical complication, frequently resulting in the rapid development of severe peritonitis, septic shock, and multiple organ dysfunction. Ostomy, the current standard of care to reduce the risk of anastomotic leakage, is a traumatic and aggressive process that significantly reduces the quality of life of patients and entails its own complications.
Latest Surgical Techniques News
- Boengineered Tissue Offers New Hope for Secondary Lymphedema Treatment
- Dual-Energy Catheter Brings New Flexibility to AFib Ablation
- 3D Bioprinting Pushes Boundaries in Quest for Custom Livers
- New AI Approach to Improve Surgical Imaging
- First-Of-Its-Kind Probe Monitors Fetal Health in Utero During Surgery
- Ultrasound Device Offers Non-Invasive Treatment for Kidney Stones
- Light-Activated Tissue Adhesive Patch Achieves Rapid and Watertight Neurosurgical Sealing
- Minimally Invasive Coronary Artery Bypass Method Offers Safer Alternative to Open-Heart Surgery
- Injectable Breast ‘Implant’ Offers Alternative to Traditional Surgeries
- AI Detects Stomach Cancer Risk from Upper Endoscopic Images
- NIR Light Enables Powering and Communicating with Implantable Medical Devices
- Simple Bypass Protocol Improves Outcomes in Chronic Cerebral Occlusion
- Implantable Absorbable Sensor Detects Life-Threatening Complications After Intestinal Surgery
- New Study Findings Enable Improved Ventilation During Complex Lung Surgery
- 3D-Printed Blood Vessel Scaffolds Could Transform Heart Bypass Surgeries
- Novel Imaging Technique Helps View Blood Perfusion During Esophageal Surgery
Channels
Artificial Intelligence
view channelCritical Care
view channel
Innovative ‘Poop Pills’ Dramatically Improve Cancer Treatment
Immunotherapy has transformed cancer care, but many patients either fail to respond or develop severe side effects that force treatment to stop early. In kidney cancer, lung cancer, and melanoma, immune-related... Read more
High-Dose Inhaled Nitric Oxide Emerges as Promising Antimicrobial Therapy
Excessive antibiotic use has accelerated the emergence of bacterial resistance to standard therapies, fueling a global health crisis projected to cause more than 10 million deaths annually by 2050.... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read moreFirst-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel
FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
Cardiovascular disease remains the world’s leading cause of death, with nearly 18 million fatalities each year, and more than two million patients undergo open-heart surgery annually, most involving sternotomy.... Read more
WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
World Health Expo (WHX) in Dubai, formerly Arab Health, which takes place from 9-12 February 2026 at the Dubai Exhibition Centre (DEC), has officially announced the launch of a new dedicated Biotech &... Read more







